JESSICA STEWART: Open Payments
NPI 1710275011 · WEST TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 99 payments from 21 companies in 2025. Trend: 2023 $1,690 · 2024 $1,613 · 2025 $1,965
Food & beverage: $1,965
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $307 |
| Novo Nordisk Inc | 14 | $279 |
| AstraZeneca Pharmaceuticals LP | 8 | $201 |
| Axsome Therapeutics, Inc. | 7 | $188 |
| Lilly USA, LLC | 10 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $133 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Astellas Pharma US Inc | 4 | $89 |
| Amgen Inc. | 5 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
Products named: Auvelity, CAPLYTA, REXULTI, VRAYLAR, FARXIGA, QULIPTA, MOUNJARO, Rybelsus.
Industry payments across IN — which companies pay providers there.
